Latest Vection Technologies (ASX:VR1) News

Small-cap shares delivered the week’s biggest moves, led by Mamba’s exploration funding and Cettire’s rebound. Clinical failures, cash shortages and delayed projects kept the broader market cautious.

Defence, artificial intelligence and government contracts drove the week’s biggest technology share moves, while several smaller companies warned they may need more cash.
Micro-X, RMA Global and Stakk led the price rises, but refinancing pressure remained a major concern across the sector.

Vection Technologies delivered its first positive full-year operating cash flow and a sharp rise in adjusted EBITDA in FY26. Yet the audited report warns that continued operations depend on stronger sales, margin gains, cost reductions and potential access to further capital.

Technology shares delivered mixed results as new contracts lifted some companies while losses and cash needs weighed on others.
Adisyn, Zimi and RocketBoots drew the biggest moves, but several businesses still need fresh funding or stronger sales.

Vection Technologies has signed reciprocal five-year reseller agreements with Xerox, opening a potential Western European channel for its conversational AI, digital human, kiosk and XR technologies. The opportunity is strategically notable, but the agreements contain no minimum volumes, pricing or committed revenue.

Small-cap shares produced another uneven week, led by a major fall in Corporate Travel Management and strong gains in energy, gas and takeover stocks.
Investors rewarded rising profits and new deals, but sold several companies despite promising project news.

Small technology shares delivered a mixed week, with Cycliq and Identitii leading the biggest reported gains while several companies fell despite new deals or technical progress.
Investors rewarded stronger cash results, but continued to question losses, new share issues and early-stage projects.

Vection Technologies (ASX:VR1) achieved a major earnings inflection in FY26 with adjusted EBITDA soaring 596% to $3.8 million and generating positive operating cash flow for the first time, underpinned by dual commercial platforms scaling rapidly.

Small-cap technology shares swung widely as capital raises, AI deals and takeover news drove the week.
Strong operating results lifted several established names, while fraud and funding concerns weighed on others.

Vection Technologies has locked in $1.2 million in non-repayable government funding to advance four distinct R&D projects spanning AI, Extended Reality, digital health, and inclusive technology.

Appen led the technology market with a 45.73% weekly rise, while Synertec and InteliCare also gained more than 27%.
AI services, defence systems, critical infrastructure and recurring software revenue drove the week’s strongest company updates.

Vection Technologies has turned a corner with its first full-year positive operating cash flow, underpinned by $41.5 million in customer receipts and over $17 million in new orders announced around the year-end.